These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35566780)

  • 1. Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?
    Czajkowska A; Guzinska-Ustymowicz K; Pryczynicz A; Lebensztejn D; Daniluk U
    J Clin Med; 2022 May; 11(9):. PubMed ID: 35566780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.
    Wang YD; Yan PY
    World J Gastroenterol; 2006 Oct; 12(37):6050-3. PubMed ID: 17009408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis.
    Mäkitalo L; Piekkala M; Ashorn M; Pakarinen M; Koivusalo A; Karikoski R; Natunen J; Saarialho-Kere U; Rintala R; Kolho KL
    World J Gastroenterol; 2012 Aug; 18(30):4028-36. PubMed ID: 22912554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Cyclophilin A Correlates with Increased Tissue MMP-9 in Patients with Ulcerative Colitis, but Not with Crohn's Disease.
    Piechota-Polanczyk A; Włodarczyk M; Sobolewska-Włodarczyk A; Jonakowski M; Pilarczyk A; Stec-Michalska K; Wiśniewska-Jarosińska M; Fichna J
    Dig Dis Sci; 2017 Jun; 62(6):1511-1517. PubMed ID: 28391416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis.
    Wang YD; Tan XY; Zhang K
    Mediators Inflamm; 2009; 2009():275072. PubMed ID: 19911067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in clinical characterisation of children with newly diagnosed Crohn's disease.
    Daniluk U; Daniluk J; Guzinska-Ustymowicz K; Pryczynicz A; Lebensztejn D
    J Paediatr Child Health; 2020 Aug; 56(8):1233-1241. PubMed ID: 32364307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between biomarkers (calprotectin, seromucoid, metalloproteinase-3 and CRP) and clinical and endoscopic activity of ulcerative colitis in children.
    Iwańczak B; Ruczka M; Matusiewicz M; Pytrus T; Matusiewicz K; Krzesiek E
    Adv Med Sci; 2020 Sep; 65(2):259-264. PubMed ID: 32361483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.
    Wiercinska-Drapalo A; Jaroszewicz J; Flisiak R; Prokopowicz D
    World J Gastroenterol; 2003 Dec; 9(12):2843-5. PubMed ID: 14669348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of matrix metaloproteinase 2 (MMP-2), matrix metaloproteinase 9 (MMP-9) and tissue inhibitor of metaloproteinase 2 (TIMP-2) in children and adolescents with growth hormone deficiency].
    Szczepańska-Kostro J; Kowalewski M; Urban M; Gardziejczyk M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(4):257-60. PubMed ID: 17239302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metalloproteinase-3 and -9 as novel markers in the evaluation of ulcerative colitis activity in children.
    Kofla-Dłubacz A; Matusiewicz M; Krzesiek E; Noga L; Iwańczak B
    Adv Clin Exp Med; 2014; 23(1):103-10. PubMed ID: 24596011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fecal MMP-9: a new noninvasive differential diagnostic and activity marker in ulcerative colitis.
    Annaházi A; Molnár T; Farkas K; Rosztóczy A; Izbéki F; Gecse K; Inczefi O; Nagy F; Földesi I; Szűcs M; Dabek M; Ferrier L; Theodorou V; Bueno L; Wittmann T; Róka R
    Inflamm Bowel Dis; 2013 Feb; 19(2):316-20. PubMed ID: 22550024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The behavior of matrix metalloproteinase-9 in lymphocytic colitis, collagenous colitis and ulcerative colitis.
    Lakatos G; Sipos F; Miheller P; Hritz I; Varga MZ; Juhász M; Molnár B; Tulassay Z; Herszényi L
    Pathol Oncol Res; 2012 Jan; 18(1):85-91. PubMed ID: 21678108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How disease extent can be included in the endoscopic activity index of ulcerative colitis: the panMayo score, a promising scoring system.
    Bálint A; Farkas K; Szepes Z; Nagy F; Szűcs M; Tiszlavicz L; Bor R; Milassin Á; Rutka M; Fábián A; Molnár T
    BMC Gastroenterol; 2018 Jan; 18(1):7. PubMed ID: 29310593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imbalance of tissue inhibitors of metalloproteinases (TIMP) - 1 and - 4 serum levels, in patients with inflammatory bowel disease.
    Kapsoritakis AN; Kapsoritaki AI; Davidi IP; Lotis VD; Manolakis AC; Mylonis PI; Theodoridou AT; Germenis AE; Potamianos SP
    BMC Gastroenterol; 2008 Nov; 8():55. PubMed ID: 19036126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expressions of Matrix Metalloproteinases (MMP-2, MMP-7, and MMP-9) and Their Inhibitors (TIMP-1, TIMP-2) in Inflammatory Bowel Diseases.
    Jakubowska K; Pryczynicz A; Iwanowicz P; Niewiński A; Maciorkowska E; Hapanowicz J; Jagodzińska D; Kemona A; Guzińska-Ustymowicz K
    Gastroenterol Res Pract; 2016; 2016():2456179. PubMed ID: 27034654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma levels of matrix metalloproteinase-9 in chronic urticaria patients correlate with disease severity and C-reactive protein but not with circulating histamine-releasing factors.
    Tedeschi A; Asero R; Lorini M; Marzano AV; Cugno M
    Clin Exp Allergy; 2010 Jun; 40(6):875-81. PubMed ID: 20214668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of matrix metalloproteinases and their tissue inhibitors in inflammatory bowel diseases.
    Lakatos G; Hritz I; Varga MZ; Juhász M; Miheller P; Cierny G; Tulassay Z; Herszényi L
    Dig Dis; 2012; 30(3):289-95. PubMed ID: 22722554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surrogate Markers of Intestinal Inflammation in Paediatric Patients with Inflammatory Bowel Disease.
    Shentova R; Baycheva M; Kofinova D; Hadjiiski P; Yaneva P
    Folia Med (Plovdiv); 2020 Jun; 62(2):271-275. PubMed ID: 32666743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
    Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
    J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular smooth muscle cells and pericytes express MMP-1, MMP-9, TIMP-1 and type I procollagen in inflammatory bowel disease.
    Arihiro S; Ohtani H; Hiwatashi N; Torii A; Sorsa T; Nagura H
    Histopathology; 2001 Jul; 39(1):50-9. PubMed ID: 11454044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.